201 related articles for article (PubMed ID: 24103034)
1. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
[TBL] [Abstract][Full Text] [Related]
2. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population.
Ahmed S; Leslie A; Thaha MA; Carey FA; Steele RJ
Br J Surg; 2005 Apr; 92(4):478-81. PubMed ID: 15609377
[TBL] [Abstract][Full Text] [Related]
3. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
4. Lower gastrointestinal symptoms are prevalent among individuals colonoscoped within the Bowel Cancer Screening Programme.
Rajasekhar PT; Ritchie M; Rutter MD; Clifford G; Waddup G; Dempsey N; Rubin GP; Rees CJ
Colorectal Dis; 2012 Sep; 14(9):e603-7. PubMed ID: 22554066
[TBL] [Abstract][Full Text] [Related]
5. Colonoscopy in symptomatic patients with positive family history of colorectal cancer.
Charalambopoulos A; Syrigos KN; Ho JL; Murday VA; Leicester RJ
Anticancer Res; 2000; 20(3B):1991-4. PubMed ID: 10928139
[TBL] [Abstract][Full Text] [Related]
6. The misuse of the faecal occult blood test under the lower gastrointestinal two week wait rule.
Shaw AG; Lund JN; Longman C; Tierney GM; Goddard AF
Colorectal Dis; 2009 Jan; 11(1):94-6. PubMed ID: 18462248
[TBL] [Abstract][Full Text] [Related]
7. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
[TBL] [Abstract][Full Text] [Related]
8. A novel pathway for investigation of colorectal symptoms with colonoscopy or computed tomography colonography.
Sanders AD; Stevenson C; Pearson J; Burt M; McGeoch G; Hudson B; Eglinton TW
N Z Med J; 2013 Sep; 126(1382):45-57. PubMed ID: 24154769
[TBL] [Abstract][Full Text] [Related]
9. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
10. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
11. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
[TBL] [Abstract][Full Text] [Related]
12. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
[TBL] [Abstract][Full Text] [Related]
13. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
Alatise OI; Ayandipo OO; Adeyeye A; Seier K; Komolafe AO; Bojuwoye MO; Afuwape OO; Zauber A; Omisore A; Olatoke S; Akere A; Famurewa O; Gonen M; Irabor DO; Kingham TP
Cancer; 2018 Jul; 124(13):2766-2773. PubMed ID: 29645077
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
[TBL] [Abstract][Full Text] [Related]
15. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
16. Findings of diagnostic colonoscopy in young adults versus findings of screening colonoscopy in patients aged 50 to 54 years: a comparative study stratified by symptom category.
Cha JM; Kozarek RA; La Selva D; Gluck M; Ross A; Chiorean M; Koch J; Lin OS
Gastrointest Endosc; 2015 Jul; 82(1):138-45. PubMed ID: 25843617
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding.
Neugut AI; Garbowski GC; Waye JD; Forde KA; Treat MR; Tsai JL; Lee WC
Am J Gastroenterol; 1993 Aug; 88(8):1179-83. PubMed ID: 8338084
[TBL] [Abstract][Full Text] [Related]
19. Symptoms associated with finding colorectal cancer during colonoscopy.
Pullens HJ; Laheij RJ; Vleggaar FP; van Oijen MG; Siersema PD
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1295-9. PubMed ID: 24081105
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis improves survival in colorectal cancer.
Keane MG; Johnson GJ
Practitioner; 2012; 256(1753):15-8, 2. PubMed ID: 22988701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
